Evidence map›Paper›PMID 26056446›Full record

ArticleInternational journal of nanomedicine2015

Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats.

Xiaomin Liu, Rui Hu, Hongwei Lian, Yang Liu, Jing Liu, Jianwei Liu, Guimiao Lin, Liwei Liu, Xiaojian Duan, Ken-Tye Yong and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Histochemistry for Molecular Imaging in Nanomedicine.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Review
  4. Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Xiaomin LiuInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China.
Rui HuSchool of Electrical and Electronic Engineering, Nanyang Technological University, Singapore, Singapore.
Hongwei LianInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China ; Department of Emergency Medicine, Peking University Third Hospital, Beijing, People's Republic of China.
Yang LiuDepartment of Geriatric Nephrology, Chinese PLA General Hospital, Beijing, People's Republic of China.
Jing LiuInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China.
Jianwei LiuInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China.
Guimiao LinKey Lab of Biomedical Engineering, School of Medical Sciences, Shenzhen University, Shenzhen, People's Republic of China.
Liwei LiuSchool of Science, Changchun University of Science and Technology, Changchun, People's Republic of China.
Xiaojian DuanInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China.
Ken-Tye YongSchool of Electrical and Electronic Engineering, Nanyang Technological University, Singapore, Singapore.
Ling YeInstitute of Gerontology and Geriatrics, Chinese PLA General Hospital, Beijing Key Lab of Aging and Geriatrics, Beijing, People's Republic of China.
Nanyang Technological University · SGChangchun University of Science and Technology · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is one of the major chronic diseases diagnosed worldwide with a common complication of diabetic nephropathy (DN). There are multiple possible mechanisms associated with DN. Aldose reductase (AR) and Toll-like receptor 4 (TLR4) may be involved in the occurrence and development of DN. Here, we describe the distribution of AR and TLR4 in cells and renal tissues of diabetic rats through a quantum dot (QD)-based immunofluorescence technique and conventional immunohistochemistry. As a new type of nanosized fluorophore, QDs have been recognized in imaging applications and have broad prospects in biomedical research. The results of the reported study demonstrate that both the AR and the TLR4 proteins were upregulated in the renal tissues of diabetic rats. Further, to explore the relationship between AR and TLR4 in the pathogenesis of DN, a dual-color immunofluorescent labeling technique based on QDs was applied, where the expressions of AR and TLR4 in the renal tissues of diabetic rats were simultaneously observed - for the first time, as far as we are aware. The optimized QD-based immunofluorescence technique has not only shown a satisfying sensitivity and specificity for the detection of biomarkers in cells and tissues, but also is a valuable supplement of immunohistochemistry. The QD-based multiplexed imaging technology provides a new insight into the mechanistic study of the correlation among biological factors as well as having potential applications in the diagnosis and treatment of diseases.

Indexed as

Aldehyde ReductaseAnimalsDiabetes Mellitus, ExperimentalDiabetic NephropathiesFluorescent Antibody TechniqueKidneyMaleMolecular ImagingQuantum DotsRats, Sprague-DawleyToll-Like Receptor 4Up-RegulationAldehyde ReductaseTlr4 protein, ratToll-Like Receptor 4diabetic nephropathyimmunofluorescenceimmunohistochemistryTLR4

Identifiers

PMID26056446
PMCPMC4445876
OpenAlexW1960107997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.